Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion

Clinical trial NCT06968572 · RECRUITING

Trial details

NCT number: NCT06968572
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-04-11
Primary completion: 2026-03-26
Enrollment: 245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.